Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (112)
2025 (1350)
2024 (1422)
2023 (1383)
2022 (1484)
2021 (1501)
2020 (1305)
2019 (1146)
2018 (1213)
2017 (1101)
2016 (996)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (20)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (15538)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Vesterlund M
JSON
CSV
XLSX
TXT
Family name
Vesterlund
Given name
Mattias
Initials
M
ORCID
ORCID
0000-0001-9471-6592
Affiliations
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
SciLifeLab, Stockholm, Sweden.
21 publications
PubMed
DOI
Crossref
Pathway activation model for personalized prediction of drug synergy.
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
Elife
13
(-) - [2025-06-03; online 2025-06-03]
DOI
Crossref
Pathway activation model for personalized prediction of drug synergy
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
Elife
13
(-) - [2025-06-03; online 2025-06-03]
DOI
Crossref
Pathway activation model for personalized prediction of drug synergy
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
-
-
(-) - [2025-05-20; online 2025-05-20]
DOI
Crossref
Pathway activation model for personalized prediction of drug synergy
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
-
-
(-) - [2025-03-20; online 2025-03-20]
DOI
Crossref
Author response: Pathway activation model for personalized prediction of drug synergy
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
-
-
(-) - [2025-03-20; online 2025-03-20]
PubMed
DOI
Crossref
The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.
Hägerstrand D
,
Oder B
, Cortese D, ..., Sutton LA,
Rosenquist R
Leukemia
38
(11) 2429-2442 [2024-11-00; online 2024-09-11]
DOI
Crossref
Pathway activation model for personalized prediction of drug synergy
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
-
-
(-) - [2024-08-09; online 2024-08-09]
DOI
Crossref
Pathway activation model for personalized prediction of drug synergy
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
-
-
(-) - [2024-06-08; online 2024-06-08]
PubMed
DOI
Crossref
Delineating functional and molecular impact of ex vivo sample handling in precision medicine.
Struyf N
,
Österroos A
,
Vesterlund M
, ...,
Seashore-Ludlow B
,
Erkers T
NPJ Precis Oncol
8
(1) 38 [2024-02-19; online 2024-02-19]
DOI
Crossref
Delineating functional and molecular impact of ex vivo sample handling in precision medicine
Erkers T, Struyf N, Arnroth C, ..., Kallioniemi O,
Seashore-Ludlow B
-
-
(-) - [2023-07-26; online 2023-07-26]
PubMed
DOI
Crossref
Prediction model for drug response of acute myeloid leukemia patients.
Trac QT, Pawitan Y, Mou T, ..., Kallioniemi O,
Vu TN
NPJ Precis Oncol
7
(1) 32 [2023-03-24; online 2023-03-24]
PubMed
DOI
Crossref
Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children.
Stratmann S
,
Vesterlund M
,
Umer HM
, ...,
Lehtiö J
,
Holmfeldt L
Leukemia
37
(3) 550-559 [2023-03-00; online 2022-12-26]
PubMed
DOI
Crossref
Proteogenomics refines the molecular classification of chronic lymphocytic leukemia.
Herbst SA
,
Vesterlund M
,
Helmboldt AJ
, ...,
Lehtiö J
,
Dietrich S
Nat Commun
13
(1) 6226 [2022-10-20; online 2022-10-20]
PubMed
DOI
Crossref
SubCellBarCode: integrated workflow for robust spatial proteomics by mass spectrometry.
Arslan T
,
Pan Y
, Mermelekas G, ..., Orre LM,
Lehtiö J
Nat Protoc
17
(8) 1832-1867 [2022-08-00; online 2022-06-22]
PubMed
DOI
Crossref
Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines.
Leo IR
,
Aswad L
,
Stahl M
, ...,
Vesterlund M
,
Jafari R
Nat Commun
13
(1) 1691 [2022-03-30; online 2022-03-30]
PubMed
DOI
Crossref
Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.
Fotouhi O, Kjellin H,
Juhlin CC
, ..., Larsson C, Orre LM
Oncogene
38
(43) 6881-6897 [2019-10-00; online 2019-08-12]
PubMed
DOI
Crossref
Breast cancer quantitative proteome and proteogenomic landscape.
Johansson HJ
, Socciarelli F, Vacanti NM, ..., Børresen-Dale AL,
Lehtiö J
Nat Commun
10
(1) 1600 [2019-04-08; online 2019-04-08]
PubMed
DOI
Crossref
Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia.
Yang M
,
Vesterlund M
, Siavelis I, ...,
Lehtiö J
,
Paulsson K
Nat Commun
10
(1) 1519 [2019-04-03; online 2019-04-03]
PubMed
DOI
Crossref
Publisher Correction: Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow.
Zhu Y, Orre LM,
Johansson HJ
, ..., Branca RMM, Lehtiö J
Nat Commun
9
(1) 1852 [2018-05-08; online 2018-05-08]
PubMed
DOI
Crossref
Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow.
Zhu Y, Orre LM,
Johansson HJ
, ..., Branca RMM, Lehtiö J
Nat Commun
9
(1) 903 [2018-03-02; online 2018-03-02]
PubMed
DOI
Crossref
Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications.
Nassa G
, Giurato G, Cimmino G, ..., Weisz A,
Tarallo R
Sci Rep
8
(1) 498 [2018-01-11; online 2018-01-11]
SciLifeLab Data Centre
Publications
9.5.1